Abbott CEO Robert B Ford appointed Chairman of the Board

Published On 2021-12-14 18:00 GMT   |   Update On 2021-12-14 12:19 GMT

ABBOTT PARK, Ill.: Abbott announced that its Board of Directors has elected Chief Executive Officer Robert B. Ford as Chairman of the Board, effective December 10. Miles D. White, executive chairman and former CEO, will step down from the Abbott Board effective December 10 and will retire after a remarkable 38-year career with the Company.

"We're grateful for Miles' leadership and his exceptional work to transform Abbott into the leading health technology company that it is today," said William A. Osborn, lead director and chair of the Nominations and Governance committee. "Robert has continued to strengthen Abbott's position by advancing our industry-leading pipeline while managing the Company's significant contributions during the pandemic."

"It's been my privilege to serve Abbott and its many stakeholders, reshaping the Company to keep it relevant and strong while medicine, technology and society have evolved," said Mr. White. "Abbott will be in good hands with Robert's leadership, and I want to thank the Board and my colleagues – current and past – for their support during my tenure."

Read also: Abbott raises annual earnings outlook as COVID test sales rebound

Advertisement

"I want to thank Miles for all he's done for Abbott and the people we serve, as well as his mentorship and friendship throughout my career," said Mr. Ford. "It's my honor to work alongside the Board and my global team to deliver on the unprecedented opportunities in front of us, so Abbott continues to lead in the reshaping of the future of healthcare."

Read also: Abbott claims its COVID tests can detect virus from omicron variant

Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News